BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma
Talamo, G, Claxton, D F, Dougherty, D W, Ehmann, C W, Sivik, J, Drabick, J J, Rybka, W
Published in Bone marrow transplantation (Basingstoke) (01.08.2009)
Published in Bone marrow transplantation (Basingstoke) (01.08.2009)
Get full text
Journal Article
P06.01.A HAS THE USE OF DUAL AGENT IMMUNOTHERAPY BEEN ALTERING THE INCIDENCE OF MELANOMA BRAIN METASTASES? A POPULATION-LEVEL ANALYSIS AND SINGLE-INSTITUTION VALIDATION
Salmanian, S, Bhanja, D, Wilding, H, Moeckel, C, Hong, J, Dao, J, Baroz, A, Stahl, C, Sivik, J, Drabick, J, Pameijer, C, Mansouri, A
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Get full text
Journal Article
High-dose melphalan on day 2 versus 1 before autologous stem cell transplantation for multiple myeloma
Rakszawski, K., Drabick, J. J., Dolloff, N. G., Sivik, J. M., Malysz, J., Claxton, D., Ehmann, W. C., Rybka, W. B., Talamo, G.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and non-diabetic patients in general clinical practice
Agostino, N. M., Chinchilli, V. M., Koszyk-Szewczyk, A. M., Gingrich, R., Sivik, J. M., Drabick, J. J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Central neurotoxicity of immunomodulatory drugs in multiple myeloma
Patel, Urmeel H, Mir, Muhammad A, Sivik, Jeffrey K, Raheja, Divisha, Pandey, Manoj K, Talamo, Giampaolo
Published in Hematology reports (03.03.2015)
Published in Hematology reports (03.03.2015)
Get full text
Journal Article